13F-HR filed by PFM Health Sciences, LP
PFM Health Sciences, LP filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 85 holding rows worth $3,400,845,000.
- Accession
- 0001104659-21-139147
- Filer
- CIK 1442756
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 85 entries on the cover page, a total value of $3,400,845,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,400,845,000 with VALUE read as thousands by filing date, 13F file number 028-13169. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 1,561,290 | $171,024,000 | thousands by filing date | |
| OUTSET MEDICAL INC | 690145107 | COM | 2,966,712 | $146,674,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 525,455 | $121,406,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 3,431,010 | $119,639,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 3,159,701 | $112,928,000 | thousands by filing date | |
| AbbVie,Inc. | 00287Y109 | COM | 916,496 | $98,862,000 | thousands by filing date | |
| ERASCA INC COM | 29479A108 | Stock | 5,191,405 | $98,172,000 | thousands by filing date | |
| HCA Healthcare Inc | 40412C101 | COM | 390,507 | $94,784,000 | thousands by filing date | |
| MYRIAD GENETICS INC | 62855J104 | COM | 2,872,918 | $92,767,000 | thousands by filing date | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 4,092,309 | $88,176,000 | thousands by filing date | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 357,916 | $85,735,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 2,079,657 | $85,058,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 864,079 | $82,874,000 | thousands by filing date | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 520,786 | $72,061,000 | thousands by filing date | |
| MCKESSON CORP COM | 58155Q103 | Stock | 349,181 | $69,620,000 | thousands by filing date | |
| GILEAD SCIENCES INC | 375558903 | COM | 963,700 | $67,314,000 | thousands by filing date | call |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 3,283,570 | $63,077,000 | thousands by filing date | |
| SEAGEN INC | 81181C104 | COM | 364,630 | $61,914,000 | thousands by filing date | |
| UNITEDHEALTH GROUP INC | 91324P902 | CALL | 157,200 | $61,424,000 | thousands by filing date | call |
| CENTENE CORP DEL COM | 15135B101 | Stock | 984,871 | $61,367,000 | thousands by filing date | |
| SELECT SECTOR SPDR TR | 81369Y905 | CALL | 1,602,200 | $60,131,000 | thousands by filing date | call |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 513,005 | $58,077,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 145,295 | $56,773,000 | thousands by filing date | |
| HUMANA INC COM | 444859102 | Stock | 139,420 | $54,255,000 | thousands by filing date | |
| Danaher Corporation | 235851102 | COM | 175,690 | $53,487,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 300,545 | $53,169,000 | thousands by filing date | |
| ICU MED INC | 44930G107 | COM | 220,587 | $51,481,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PUB L | G46188901 | Equity Call | 439,400 | $48,132,000 | thousands by filing date | call |
| BIOMARIN PHARMACEUTICAL INC | 09061GAH4 | NOTE 0.599% 8/0 | 45,910,000 | $47,675,000 | thousands by filing date | principal |
| PENUMBRA INC COM | 70975L107 | Stock | 177,088 | $47,194,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 785,748 | $47,192,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 666,601 | $46,562,000 | thousands by filing date | |
| NEVRO CORP | 64157F103 | COM | 392,786 | $45,712,000 | thousands by filing date | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 667,073 | $44,320,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771VAB4 | NOTE 1.500%10/0 | 48,150,000 | $44,256,000 | thousands by filing date | principal |
| WATERS CORP COM | 941848103 | Stock | 117,634 | $42,031,000 | thousands by filing date | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 158,183 | $41,447,000 | thousands by filing date | |
| NOVAVAX INC | 670002401 | COM NEW | 197,208 | $40,883,000 | thousands by filing date | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 71,442 | $40,817,000 | thousands by filing date | |
| BRISTOL-MYERS SQUIBB CO | 110122908 | CALL | 612,000 | $36,212,000 | thousands by filing date | call |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,856,738 | $35,482,000 | thousands by filing date | |
| SOPHIA GENETICS SA | H82027105 | ORDINARY SHARES | 2,022,552 | $35,455,000 | thousands by filing date | |
| HERON THERAPEUTICS INC | 427746102 | COM | 2,993,546 | $32,001,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 3,848,822 | $28,597,000 | thousands by filing date | |
| CANO HEALTH INC | 13781Y103 | COM | 2,094,279 | $26,555,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C909 | COM | 261,500 | $25,080,000 | thousands by filing date | call |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 2,182,684 | $24,883,000 | thousands by filing date | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 178,222 | $23,908,000 | thousands by filing date | |
| CATALENT INC USD 0.01 | 148806102 | COM | 177,800 | $23,660,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 4,403,574 | $22,766,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 177,091 | $21,664,000 | thousands by filing date | |
| IONIS PHARMACEUTICALS INC | 462222AB6 | NOTE 0.125%12/1 | 23,000,000 | $21,133,000 | thousands by filing date | principal |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 775,819 | $19,939,000 | thousands by filing date | |
| BUTTERFLY NETWORK INC | 124155102 | COM CL A | 1,828,311 | $19,088,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 70,088 | $19,016,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 1,138,112 | $18,483,000 | thousands by filing date | |
| STEVANATO GROUP S P A ORD SHS | T9224W109 | Stock | 549,002 | $13,895,000 | thousands by filing date | |
| SIGHT SCIENCES INC | 82657M105 | COMMON STOCK | 483,538 | $10,976,000 | thousands by filing date | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 302,532 | $10,607,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 84,455 | $10,558,000 | thousands by filing date | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 99,375 | $10,473,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158901 | COM NEW | 521,800 | $10,024,000 | thousands by filing date | call |
| PARDES BIOSCIENCES INC COM | 30318F100 | Stock | 1,000,000 | $9,950,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 17,510 | $9,576,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 288,334 | $8,592,000 | thousands by filing date | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 455,374 | $8,420,000 | thousands by filing date | |
| HUMANA INC | 444859902 | COM | 21,000 | $8,172,000 | thousands by filing date | call |
| NOVAVAX INC | 670002AB0 | NOTE 3.750% 2/0 | 4,250,000 | $7,354,000 | thousands by filing date | principal |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 400,000 | $6,864,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 980,505 | $6,462,000 | thousands by filing date | |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 443,595 | $6,432,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 264,293 | $6,084,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 136,576 | $4,914,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 143,297 | $4,869,000 | thousands by filing date | |
| BIOGEN INC COM | 09062X103 | Stock | 16,900 | $4,783,000 | thousands by filing date | |
| CERTARA INC COM | 15687V109 | Stock | 143,028 | $4,734,000 | thousands by filing date | |
| BCLS ACQUISITION CORP | G0904B105 | CMN | 464,103 | $4,641,000 | thousands by filing date | |
| JIYA ACQUISITION CORP | 47760M102 | CMN | 464,103 | $4,539,000 | thousands by filing date | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 544,706 | $4,208,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T905 | COM | 15,000 | $2,654,000 | thousands by filing date | call |
| BEYONDSPRING INC | G10830100 | SHS | 161,697 | $2,548,000 | thousands by filing date | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 65,000 | $2,480,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 188,243 | $1,879,000 | thousands by filing date | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A907 | SPONDS ADS | 291,800 | $1,509,000 | thousands by filing date | call |
| Allena Pharmaceuticals, Inc. | 018119107 | COM | 284,285 | $256,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-21-139147 | this filing | 2021-11-15 | acceptance time not in the bulk data set |